Research output per year
Research output per year
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Pharmacy is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
24th ISoP Annual Meeting "Pharmacovigilance: Back to the Future" 24-27 October 2025 Cairo, Egypt: Abstract: A Nationwide post-marketing pharmacogvigilance study of darunavir employing suspected adverse drug reactions submitted to the United Kingdom’s Medicines and Healthcare products Regulatory Agency
Pono, P. & Jones, A. M., 15 Jul 2025, (Accepted/In press) In: Drug Safety.Research output: Contribution to journal › Abstract › peer-review
-
669P Mapping the neoantigen landscape of glioma in the UK brain cancer vaccine project
Bryan, M. E., Weatherseed, M., Cheng, V. W. T., Blagden, S. P., Ince, W., Mair, R., Sim, M., Schuh, A., Adamopoulou, E., Watson, R., Middleton, M. R., Leung, C. S. K., Elliott, T. & Lee, L. Y. W., 5 Nov 2025, In: Annals of Oncology. 36, Supplement 2, p. S487-S487 1 p.Research output: Contribution to journal › Abstract › peer-review
-
Adverse Drug Reaction Profiles of Histone Deacetylase Inhibitors
Begum, R., Parsons, J. L. & Jones, A. M., 14 Oct 2025, In: Scientific Reports. 15, 1, 12 p., 35880.Research output: Contribution to journal › Article › peer-review
Open AccessFile13 Downloads (Pure)
-
Development and In Vivo Evaluation of Novel EAAT1 Inhibitors for Their Capacity to Suppress T-Cell Acute Lymphoblastic Leukaemia
Jones, A. (Co-Investigator) & Hoogenkamp, M. (Principal Investigator)
1/12/25 → 30/11/27
Project: Research
-
3D Spheroid Boron Quantification for BNCT Drug Development
Coverdale, J. (Principal Investigator)
1/11/25 → 31/10/26
Project: Research Councils
-
TenBoron Pilot: Exploiting the potential for Tenboron's novel Boron carriers to improve the biological effectiveness of BNCT
Coverdale, J. (Co-Investigator) & Parsons, J. (Principal Investigator)
1/09/25 → 31/03/26
Project: Research
Activities
-
National Science Centre, Poland (Publisher)
Jones, A. (Chair)
Mar 2026Activity: Publication peer-review and editorial work › Grant peer review
-
EU evaluation exercise. Marie Skłodowska-Curie Staff Exchanges HORIZON-MSCA-2025-SE-01. Scientific Panel - Life Sciences (LIF) (Event)
Jones, A. (Chair)
Dec 2025Activity: Publication peer-review and editorial work › Grant peer review
-
Birmingham and Solihull Mental Health NHS Foundation Trust
Jones, A. (Advisor)
12 Nov 2025 → 31 Aug 2027Activity: Collaboration with an external institution or individual › Collaboration
Datasets
-
Raw data from observations of SSRI-suspected ADRs from the Yellow Card System-March 2025
Man, L. Y. M. (Creator) & Jones, A. (Supervisor), University of Birmingham, 17 Jul 2025
DOI: 10.25500/edata.bham.00001322
Dataset
-
The impact of computerised physician order entry and clinical decision support on pharmacist-physician communication in the hospital setting: a qualitative study
Pontefract, S. (Creator), University of Birmingham, 2018
DOI: 10.25500/eData.bham.00000207
Dataset
-
Data accompanying the paper "A sulfuryl group transfer strategy to selectively prepare sulfated steroids and isotopically labelled derivatives"
Jones, A. (Creator), University of Birmingham, 17 Sept 2021
DOI: 10.25500/edata.bham.00000720
Dataset
Prizes
-
1st prize at the Bioinspired Material Research Symposium, Manchester, UK
Jones, A. (Recipient), 2016
Prize: Prize (including medals and awards)
-
Advanced HE - Certificate of Professional Development Course for External Examiners
Jones, A. (Recipient), Jul 2023
Prize: Other distinction
-
Press/Media
-
Fluorine “forever chemical” in medicines not leading to added drug reactions
2/09/25
1 Media contribution
Press/Media: Press / Media
-
The potent oxidant anticancer activity of organoiridium catalysts
1/03/14 → 26/03/14
5 items of Media coverage, 1 Media contribution
Press/Media: Press / Media